1. Targeting c-Myc with decoy oligodeoxynucleotide-loaded polycationic nanoparticles inhibits cell growth and induces apoptosis in cancer stem-like cells (NTERA-2)
   Roghayeh Ghorbani et al, 2024, Molecular Biology Reports CrossRef
2. HDAC-an important target for improving tumor radiotherapy resistance
   Rui Ling et al, 2023, Frontiers in Oncology CrossRef
3. [Retracted] Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c‐myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses
   Jin Qian et al, 2022, BioMed Research International CrossRef
4. Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
   Don W. Coulter et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
5. The roles of glycolysis in osteosarcoma
   Zuxi Feng et al, 2022, Frontiers in Pharmacology CrossRef
6. Umbelliprenin improved anti-proliferative effects of ionizing radiation on adult T-cell leukemia/lymphoma cells via interaction with CDK6; an in vitro and in silico study
   Keyhan Ebrahimi et al, 2024, International Journal of Immunopathology and Pharmacology CrossRef
7. Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin
   Ramin Bagheri et al, 2022, Dose-Response CrossRef
8. ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma
   Yanlin Song et al, 2023, Cancer Letters CrossRef